Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Jan de Kerpel

Managing Director, Head of Life Science & Healthcare, Kempen & Co

Keynote speech VIP & CEO-Investor Dinner

Dr Jan De Kerpel is a recognized biotech/healthcare business and finance expert with more than 20 years of experience in the fields of drug development, equity analysis and capital market growth financing. He currently serves as Managing Director Corporate Finance Life Science/Healthcare at Kempen. Prior to Kempen, he was during one decade Senior Equity Analyst, Pharma & Biotech at KBC Securities, which earned him 3 times the Financial Times/Starmine “Best European Biotech analyst” award. He started his professional activities in drug development at Tibotec-Virco (now JNJ) and Devgen (now Syngenta).

Jan has a proven track record in successfully identifying investment opportunities to a continuously expanding international investor base and has been instrumental in raising close to €1 billion in IPOs and other equity financing for numerous Benelux biotech, medtech, health services and pharmaceutical companies. Until recently, Jan served as board member of FlandersBio and is an invited speaker on topics relating healthcare innovation, strategic development with financing.

Academically, Jan earned a master and PhD in life sciences (Univ Leuven), postgraduate in Business Administration (Univ Leuven) and an executive MBA (Vlerick Business School), complemented with corporate finance classes (Univ Brussels).
Marcel Levi
University College London Hospitals
Annemarie Jorritsma
NVP
Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

Claudia Rijcken
pharmi

Inge Huitinga
Netherlands Brain Bank
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Els Beirnaert
Aelin Therapeutics
Joep Muijrers
PureTech Health
Esther Talboom-Kamp
Saltro Diagnostics
Elise Meijer
Antwerp Management School & Accenture Strategy
Carine van den Brink
Axon Lawyers
Tim Knotnerus
AgomAb Therapeutics
Sjaak Vink
TheSocialMedwork
Hans Schikan
Topsector Life Sciences & Health
Thijn Brummelkamp
Scenic Biotech
Michel Dumontier
Maastricht University
Dharminder Chalal
SkylineDx, Van Herk Investsments, Swanbridge

Marianne van der Steen
RegMedXB & Maastricht University

Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.